Correlation Between Tonix Pharmaceuticals and Ocuphire Pharma
Can any of the company-specific risk be diversified away by investing in both Tonix Pharmaceuticals and Ocuphire Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tonix Pharmaceuticals and Ocuphire Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tonix Pharmaceuticals Holding and Ocuphire Pharma, you can compare the effects of market volatilities on Tonix Pharmaceuticals and Ocuphire Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tonix Pharmaceuticals with a short position of Ocuphire Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tonix Pharmaceuticals and Ocuphire Pharma.
Diversification Opportunities for Tonix Pharmaceuticals and Ocuphire Pharma
0.81 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Tonix and Ocuphire is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding Tonix Pharmaceuticals Holding and Ocuphire Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ocuphire Pharma and Tonix Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tonix Pharmaceuticals Holding are associated (or correlated) with Ocuphire Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ocuphire Pharma has no effect on the direction of Tonix Pharmaceuticals i.e., Tonix Pharmaceuticals and Ocuphire Pharma go up and down completely randomly.
Pair Corralation between Tonix Pharmaceuticals and Ocuphire Pharma
If you would invest 18.00 in Tonix Pharmaceuticals Holding on August 27, 2024 and sell it today you would earn a total of 1.00 from holding Tonix Pharmaceuticals Holding or generate 5.56% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 4.76% |
| Values | Daily Returns |
Tonix Pharmaceuticals Holding vs. Ocuphire Pharma
Performance |
| Timeline |
| Tonix Pharmaceuticals |
| Ocuphire Pharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Tonix Pharmaceuticals and Ocuphire Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tonix Pharmaceuticals and Ocuphire Pharma
The main advantage of trading using opposite Tonix Pharmaceuticals and Ocuphire Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tonix Pharmaceuticals position performs unexpectedly, Ocuphire Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ocuphire Pharma will offset losses from the drop in Ocuphire Pharma's long position.| Tonix Pharmaceuticals vs. Sonnet Biotherapeutics Holdings | Tonix Pharmaceuticals vs. Palisade Bio | Tonix Pharmaceuticals vs. Ibio Inc | Tonix Pharmaceuticals vs. Jaguar Animal Health |
| Ocuphire Pharma vs. Reviva Pharmaceuticals Holdings | Ocuphire Pharma vs. Protalix Biotherapeutics | Ocuphire Pharma vs. Eyepoint Pharmaceuticals | Ocuphire Pharma vs. Sellas Life Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |